©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Unfolding Pathway in Red Kidney Bean Acid Phosphatase Is Dependent on Ligand Binding (*)

(Received for publication, November 3, 1995; and in revised form, November 25, 1995)

Anil G. Cashikar Nalam Madhusudhana Rao (§)

From the Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Structural basis for ligand-induced protein stabilization was investigated in the case of an acid phosphatase (red kidney bean purple acid phosphatase (KBPAP)) from red kidney bean. Phosphate, a physiological ligand, increases the stability against solvent denaturation by 3.5 kcal/mol. Generality of phosphate stabilization was shown by similar effects with other KBPAP ligands viz. adenosine 5`-O-(thiotriphosphate), a nonhydrolyzable ligand, and arsenate, an inhibitor. The dissociation constant of phosphate obtained from denaturation curves matches with the dissociation constant estimated by conventional methods. The guanidinium chloride-mediated denaturation of KBPAP was monitored by several structural and functional parameters viz. activity, tryptophan fluorescence, 8-anilinonaphthalene 1-sulfonic acid binding, circular dichroism, and size exclusion chromatography, in the presence and absence of 10 mM phosphate. In the presence of phosphate, profiles of all the parameters shift to a higher guanidinium chloride concentration. Noncoincidence of these profiles in the absence of phosphate indicates multistate unfolding pathway for KBPAP; however, in the presence of phosphate, KBPAP unfolds with a single intermediate. Based on the crystal structure, we propose that the Arg may have an important role to play in stabilization mediated by phosphate.


INTRODUCTION

Increase in the free energy upon ligand binding to a protein could translate into specific conformational changes that may have stabilizing or destabilizing effects on the protein(1, 2) . Native proteins are only marginally more stable than the denatured proteins (3) . Since unfolded proteins are better substrates for proteolytic degradation, ligand-mediated stabilization was considered to have influence on the protein turnover(3, 4) . Physiological ligands such as substrate analogues, inhibitors, etcetera were shown to enhance enzyme stability(5, 6, 7) . Conformational rearrangements in a protein on ligand binding was documented, and in several instances ligand-protein complexes were crystallized(8, 9) . Ligand-induced enzyme stabilization was quantitated by the protective role ligand binding plays against denaturation, e.g. heat or denaturant, and the reported values of the energy of stabilization were in the range of 1-4 kcal/mole(10, 11) . However, the causal relation between the ligand-induced structural changes and the ensuing stability was not addressed. It would be of interest to know whether the ligand merely shifts the unfolding pathway to a higher value on a temperature/denaturant scale or if it alters the way the protein responds to temperature/denaturant, i.e. alters the unfolding pathway. Such information would be of interest in our attempt to design enzymes with improved stability(6) .

Acid phosphatase from red kidney beans (KBPAP) (^1)is a homodimeric glycoprotein with a subunit molecular mass of 55 kDa(12, 13, 14, 15) . The binuclear metal center of the protein with a tyrosine to Fe(II) charge transfer transition was responsible for its characteristic purple color(15) . Based on amino acid sequence alignment, it was shown that the protein has betaalphabetaalphabeta motif and has same amino acids ligating the metal ions as in uteroferrin, its mammalian counterpart(16) . The N-terminal 120-amino acid stretch was absent in uteroferrin and does not have any active site or metal ion-ligating amino acid residues(16) . The enzyme has limited subunit interactions between the alpha5 helix and a loop formed by amino acids from 253 to 260 beside an intersubunit disulfide bond at Cys(17) . KBPAP shows a rather narrow substrate specificity toward ATP, unlike other plant acid phosphatases, and its exact physiological function has not been ascertained until recently (18) . Plant acid phosphatases have been observed to be intimately involved in plant phosphate metabolism(19) . We observed significant enhancement in the stability of KBPAP toward solvent and heat denaturation in the presence of phosphate. In this communication, we report data on the influence of phosphate binding on the denaturation pathway of KBPAP and demonstrate that phosphate not only stabilizes KBPAP to denaturation but also alters the unfolding pathway.


EXPERIMENTAL PROCEDURES

Materials

Guanidinium chloride (GdmCl) was from Serva Feinbiochemica GmBH & Co. (Germany); 8-anilinonaphthalene 1-sulfonic acid (ANS) was from Aldrich Chemical Co.; p-nitrophenyl phosphate was from Sisco Research Laboratory (India); Superose 12 gel filtration column and the FPLC system were from Pharmacia LKB Biotechnology (Sweden); water used for the experiments was purified over a Milli-Q water purification system from Millipore.

Methods

Protein Purification

Purification of the red kidney bean purple acid phosphatase was according to the procedures described earlier(12, 13) . The KBPAP purified from a local variety of beans shows small differences in amino acid composition but matches with the reported enzyme in substrate specificity, number, and location of disulfide bond and molecular weight(14, 15, 16, 17) .

Denaturation of Protein

GdmCl stock solutions were made in Milli-Q water, and the concentration was determined by measuring the refractive index on a Schmidt-Haensch-DUR refractometer thermostated at 25 °C. The denaturation mix contained 10 mM Tris buffer (pH 7.4), 500 mM NaCl, and necessary concentrations of GdmCl with or without 10 mM NaH(2)PO(4). The protein was incubated in the denaturing mix for 24 h at 25 °C except in case of tryptophan fluorescence quenching by potassium iodide, wherein the enzyme was incubated for 6 h.

Enzymatic Activity

Enzyme activity was measured by diluting an aliquot of the enzyme at the appropriate concentration of GdmCl into reaction mix containing 50 mM sodium acetate buffer (pH 5), 500 mM NaCl, and 10 mMp-nitrophenyl phosphate. The reaction was stopped by addition of 2 volumes of 0.5 M NaOH. Absorbance measured at 410 nm was corrected with respective blanks. Binding constant of phosphate to KBPAP was calculated from the denaturation curves by using nonparametric methods (20) .

Circular Dichroism (CD)

CD spectra were recorded on a Jobin-Yvon Autodichrograph Mark V spectropolarimeter. A protein concentration of 0.1 mg/ml in the denaturing mix as indicated in the earlier section and pathlength of 1 mm was used. Base-line corrections were done by subtracting the buffer spectra from the sample spectra.

Fluorimetry

Fluorescence spectra were recorded on Hitachi F-4010 spectrofluorimeter. Intrinsic tryptophan fluorescence spectra were recorded by exciting the sample at 295 nm with excitation and emission slit widths set at 5 nm each. Protein concentration was 0.1 mg/ml. DeltaG values were calculated using the tryptophan emission wavelength maxima (max) obtained at various GdmCl concentrations, according to the equation DeltaG = -RT(lnK), where K = ( - (N))/((D) - ) and (N) and (D) are max of the native and the denatured protein, respectively.

Potassium iodide quenching of tryptophan fluorescence was done on the protein incubated at various concentrations of GdmCl for 6 h at 25 °C. A stock of potassium iodide was prepared in buffer containing the respective concentration of GdmCl. Small aliquots of this stock were added to the denatured protein up to a final potassium iodide concentration of 0.25 M. Fluorescence spectra were recorded after each addition. The intensities at 340 nm were corrected for the increase in volume after addition of potassium iodide. Stern-Volmer quenching constants (K) were calculated by established procedures(21) .

ANS fluorescence spectra were recorded after adding twice-crystallized ANS to the protein sample to a final concentration of 112 µM. Excitation wavelength was set at 350 nm with a slit width of 10 nm. Emission spectra were recorded between 450 and 570 nm with a slit width of 5 nm. Base-line corrections were done with buffer without protein in all cases.

Size Exclusion Chromatography (SEC)

SEC was performed on the Superose 12 column on a Pharmacia FPLC system(22) . The column was routinely calibrated using the manufacturer's instructions and found that the reproducibility of elution volumes of standards was accurate to 99%, even after extensive use. The column was equilibrated with solutions identical to the solutions in which protein was incubated. Protein was denatured by preincubating in various GdmCl concentration for 24 h at 25 °C before loading onto the column. Protein elution was monitored at 280 nm. The elution profiles were deconvoluted using a commercial software (Jandel Corp.), and mole ratios of different fractions were computed.


RESULTS

Activity

Stabilization of KBPAP on phosphate binding was most significant in case of its activity (Table 1). The D of the activity profile in the presence of phosphate increased by 2.3 M GdmCl, in comparison to that in the absence of phosphate (Fig. 1A). Denaturation transition was steeper in the presence of phosphate. Similar shifts in D were also observed with ATPS, a nonhydrolyzable substrate analogue, and arsenate, an inhibitor of KBPAP (Fig. 1B and Table 1). With ATPS, we consistently observed a 2.5-fold enhancement in activity in GdmCl.




Figure 1: Enzymatic activity as a function of GdmCl concentration in the presence of ligands or effectors. A, presence (solid circles) and absence (open circles) of 10 mM phosphate in the denaturation mix. B, presence of 1 mM ATPS (triangles) or 10 mM sodium arsenate (squares) in the denaturation mix. C, denaturation in the presence (solid circles) or absence (open circles) of 10 mM phosphate (24 h) was followed by incubation with 50 mM beta-mercaptoethanol (3 h). D, plot of the midpoints of denaturation transition (D, M) as a function of phosphate concentration. The D values were obtained from experiments similar to A at several phosphate concentrations (data not shown).



KBPAP is a homodimer with an intersubunit disulfide bond at Cys, and an intact disulfide is necessary for native conformation and activity(13) . To study the accessibility of the intersubunit disulfide after denaturation for 24 h at 25 °C, we incubated the protein in the denaturing mix for further 3 h after addition of beta-mercaptoethanol to a final concentration of 50 mM. In the absence of phosphate, the D decreased to 1.6 M GdmCl, while in the presence of phosphate the D remained unchanged (Fig. 1C and Table 1). Even in the samples without GdmCl, a 32% loss in the specific activity was caused by beta-mercaptoethanol in the absence of phosphate and only a 7% loss in the presence of phosphate (data not shown).

Based on theoretical calculations, it was predicted that the binding constants of ligands could be calculated from the denaturation curves (23) . We calculated the binding constant of phosphate to KBPAP by plotting the D values against phosphate concentration (Fig. 1D) and obtained a binding constant of 1.2 mM, which was similar to the inhibition constant (K(i) = 1.8 mM) obtained by activity inhibition studies. The equilibrium binding constants were calculated by the non-parametric method described by Cornish-Bowden(20) . Protection by phosphate was also observed against thermal denaturation, wherein the midpoint of transition was shifted by 5 °C (data not shown).

Tryptophan Fluorescence

Tryptophan fluorescence emission intensity and wavelength are very sensitive to the polarity of its surroundings, hence Trp fluorescence was very effectively used to monitor the protein denaturation(24) . An 11-nm shift in the emission maximum and a 30% decrease in the relative fluorescence intensity was observed upon denaturation of KBPAP in 6 M GdmCl. The D of the change in max increases by 0.6 M in the presence of phosphate, and the transition is typical of a two-state transition (Fig. 2). The final state of unfolding seems to be independent of phosphate in the medium. Arsenate also brings about similar effects on Trp fluorescence as phosphate (data not reported). A red shift in the Trp fluorescence indicates increased accessibility of Trp to the bulk solvent. DeltaG of denaturation were calculated for the protein in the presence and absence of phosphate, using the tryptophan emission wavelength maxima, by the procedure described under ``Experimental Procedures''(25) . Tryptophan emission data were selected for energy calculations since the size of the data set in the transition zone was significant. We obtained values of 2.5 and 6 kcal/mol in the absence and in the presence of phosphate, respectively. This results in a ligand stabilization energy of 3.5 kcal/mol (see inset in Fig. 2). Iodide was used as a polar quencher of Trp fluorescence. Detailed quenching experiments were performed on KBPAP in various concentrations of GdmCl in the presence and absence of phosphate to obtain the Stern-Volmer constants (K) at each concentration of GdmCl(21) . K plotted against GdmCl shows a sharp increase in exposure of Trp at 3.5 M GdmCl in the absence of phosphate and at 4.5 M in the presence of phosphate (Fig. 3).


Figure 2: Tryptophan fluorescence emission wavelength maxima (max) plotted as a function of GdmCl concentration. Open circles indicate absence and solid circles indicate presence of 10 mM phosphate in the denaturation mix. The inset shows the plot of DeltaG versus GdmCl concentration. The DeltaG(H(2)O) was the intercept on the the y axis.




Figure 3: Accessibility of KBPAP tryptophan to a polar quencher, potassium iodide, measured as Stern-Volmer quenching constants (K) was plotted as a function of GdmCl concentrations. Open circles indicate absence and solid circles indicate presence of 10 mM phosphate in the denaturation mix.



ANS Fluorescence

Solvent denaturation of protein results in exposure of occluded hydrophobic pockets, which could be quantitated by binding of ANS(26) . Equilibrium binding of ANS to KBPAP enhances by more than 12-fold in 1.5 M GdmCl. ANS binding profiles reveal two peaks at 1.5 and 4 M, which were independent of phosphate (Fig. 4). In the presence of phosphate, ANS binding to KBPAP was approximately 50% of the value obtained in the absence of phosphate.


Figure 4: Binding of ANS to denatured KBPAP in various GdmCl concentrations. Fluorescence of protein-bound ANS increases by severalfold compared to the free ANS, and relative fluorescence intensity of ANS at 490 nm was plotted against GdmCl concentration. Relative fluorescence intensity of samples without GdmCl were taken as unity.



Circular Dichroism

CD of peptide backbone is an excellent parameter to study loss in protein secondary structure on solvent denaturation. Ellipticity value at 220 nm is a good indicator of the helical content in the protein. The D of protein ellipticity profile shifts to the right by 1.2 M in the presence of phosphate (Fig. 5). An initial decrease in the ellipticity value was observed at low GdmCl concentrations in the absence of phosphate at 1.5 M GdmCl, wherein ANS shows enhanced binding. Even at 6 M GdmCl the ellipticity value in the presence of phosphate does not reach the value obtained in the absence of phosphate, indicating presence of residual structure in the protein.


Figure 5: Change in mean residue ellipticity ([]) at 220 nm as a function of GdmCl. Open circles indicate absence and solid circles indicate presence of 10 mM phosphate in the denaturation mix. CD spectra were obtained at a concentration of 0.1 mg/ml using a pathlength of 1 mm.



Size Exclusion Chromatography

SEC of protein, where exchange times between various forms are longer than the separation time, is a powerful technique to study the equilibrium distribution of various intermediates during protein denaturation(22) , particular advantages of SEC being that the information on the size of the intermediates could be obtained and also intermediates could be obtained in pure form for subsequent characterization. Elution profiles of KBPAP in various concentrations of GdmCl in the absence (Fig. 6A) and presence (Fig. 6B) of phosphate were obtained on a Superose 12 column preequilibrated with respective solvents. The Stokes' radii for the native (41.7 Å), denatured dimer (101.6 Å), and denatured monomer (71.7 Å) were calculated based on a relationship according to Uversky(22) . The relative proportions of various forms of protein were obtained by deconvoluting the elution profiles using standard software (Fig. 7). The D of the native peak (peak 3) shows nearly 2 M shift to higher GdmCl in the presence of phosphate, similar to the activity profile (Table 1), whereas the appearance of denatured dimer was independent of phosphate. At 3 M GdmCl, a small and reproducible peak appears (peak 2, Fig. 7A). However, at 4 M GdmCl we obtain a significant portion, more than 90%, of the protein appearing in the void volume, i.e. larger than 300 kDa, in the absence of phosphate. Light scatter of the column eluates was monitored immediately without dilution in a L-type spectrofluorimeter set at 350 nm and excitation and emission slit widths of 5 nm. We did not find any increase in light scatter in the void volume fraction, indicating that the increase in apparent size in the void fractions may be due to self-limiting and weak aggregation, which may not be within the sensitivity limits of our light-scattering experiments. Formation of this protein fraction was nearly completely inhibited in the presence of phosphate. Various peaks were collected and checked for activity and found that except for the native fraction (peak 3), other peaks do not show any activity.


Figure 6: Elution profiles of KBPAP, on a Superose 12 column, denatured in various concentrations of GdmCl in the absence (A) or presence (B) of 10 mM phosphate in the denaturing mix. The column was preequilibrated with the solvent components identical to the incubation conditions. Peak 1 has elution volume equivalent to the void volume (5.7 ± 0.07 ml), peak 2 indicates where fully denatured protein appears, and peak 3 indicates the position of the native protein.




Figure 7: Areas under the three elution peaks at each GdmCl concentration were plotted as a function of GdmCl concentration (see Fig. 6). In the absence (A) and in the presence (B) of 10 mM phosphate. Peak 1, circles; peak 2, squares; peak 3, triangles.




DISCUSSION

To understand the structural basis of ligand-induced stabilization in KBPAP, equilibrium solvent denaturation was studied by various structural and functional parameters in the presence of its physiological ligand, phosphate. In the presence of 10 mM phosphate, D, i.e. the denaturant concentration at 50% denaturation, shifted to higher GdmCl concentration by more than 1 M, indicating substantial stabilization of KBPAP toward solvent denaturation (Table 1). A Delta (DeltaG) of 3.5 kcal/mol was obtained for phosphate protection, according to DeltaG calculations based on fluorescence data (see inset in Fig. 2). Reported ligand binding energies were in the order of 1-4 kcal/mol(2, 4, 27, 28) . Observed stabilization with ATPS, a nonhydrolyzable substrate analogue, and arsenate, an inhibitor, indicated that the stabilization were general and not specific for phosphate alone. In all these assays, enzyme was preincubated in the presence or absence of phosphate/ligand and GdmCl and assayed in the absence of phosphate/ligand and GdmCl. Phosphate was used at about 10 times its inhibitory constant in the stability experiments. We also observed that the inhibitory constant of phosphate increases with GdmCl (data not shown). Similar information was not available with ATPS as ligand, and the enhanced specific activities in 0-3 M GdmCl region may be due to decreased binding of ATPS. Phosphate inhibition was competitive in nature when studied with ATP and p-nitrophenyl phosphate as substrates, indicating that primary effect of phosphate was by binding to the active site. Ligand binding energy could, for reasons of energy conservation, have structural consequences that might stabilize or destabilize a protein (2, 4) . Such substrate effects were implicated in the protein turnover in vivo(3) . In this case, dissociation and denaturation of KBPAP mediated by GdmCl was delayed by phosphate ligation. The crystal structure of KBPAP has been reported at 2.9-Å resolution and was shown to be a homodimeric glycoprotein with an intersubunit disulfide bond (13, 17) . KBPAP has a limited subunit interface at alpha5 helix and a loop (amino acids 253-260) participating in the intersubunit interaction beside the intersubunit disulfide(17) . Reduction of the disulfide bond results in inactivation and aggregation of the protein. (^2)Here, we observe that in the presence of phosphate, accessibility of the intersubunit disulfide bond was reduced, indicating that the active site bound ligand can stabilize subunit interactions.

By overlapping various parameters on a common GdmCl scale, one could identify and approximately characterize the intermediates in the unfolding pathway(29) . Unfolding pathway of KBPAP was multistate in nature, with all the parameter profiles showing clear dependence on the presence of phosphate. At low concentrations of GdmCl, surface hydrophobicity of the KBPAP increased significantly resulting in a 12-fold increase in ANS fluorescence. Substantial suppression of ANS binding in the presence of phosphate suggests prevention of underlying structural changes by phosphate. In this concentration range of GdmCl, i.e. up to 1.5 M, except ANS binding, other parameters including activity, the most susceptible parameter to denaturation, were invariant. KBPAP has an N-terminal 120-amino acid domain, which does not have any active site amino acids and was shown to be absent in the mammalian counter part of KBPAP, uteroferrin(16) . The structural changes occurring in 0-1.5 M range of GdmCl may be limited to the N-terminal domain.

On further denaturation in the absence of phosphate, i.e. in 1.5-3 M GdmCl, we observed a 90% decrease in enzyme activity, the mole ratio of the native protein, ANS binding, and only a marginal change in fluorescence and ellipticity. In this region, KBPAP may be an inactive, swollen (probably aggregated to a limited extent) intermediate with reduced surface hydrophobicity and little change in the secondary structure but substantial loss in tertiary and quarternary structure. Phosphate at 10 mM concentration prevents all the changes induced in the range of 1.5-3 M GdmCl and apparently shifts the equilibrium of N &rlhar2; I(1) more to the left. Thus, on phosphate ligation, KBPAP in 3 M GdmCl has all the properties as a native enzyme, whereas nonligated enzyme loses most of its tertiary and quarternary structure. In the range of 3-5 M GdmCl, both in the presence and absence of phosphate, significant loss in the secondary structure and ``inside out'' opening of the protein indicated by Trp fluorescence and quenchability by a polar quencher occurs. These structural rearrangements resulted in an intermediate with a 5-fold enhancement in ANS binding and a significant portion of the protein appearing as an aggregate. Both of these events were substantially reduced by the presence of phosphate (see Fig. 4, Fig. 6, and Fig. 7). In presence of phosphate, even in 6 M GdmCl, KBPAP has residual structure, indicated by higher negative [] value compared to the value in the absence of phosphate.

In the absence of phosphate, the nonoverlapping profiles of ANS binding, activity, SEC, fluorescence, and CD demonstrate that unfolding pathway of KBPAP was multistate with at least three intermediates populating the pathway. In the presence of phosphate, the D of all of these profiles was in the narrow range of 4-4.5 M. However, SEC analysis of KBPAP denaturation was rewarding. In the range of 2-4 M GdmCl, even in the presence of phosphate, a small fraction (<20%) of the protein was in aggregated form. SEC demonstrates that the phosphate ligation to KBPAP alters the unfolding pathway with three intermediates into a pathway with a single intermediate. Additionally, in the absence of GdmCl, phosphate-induced structural changes reduce the accessibility of the intersubunit disulfide bond to the reducing agents.

To stabilize the pentacoordinate phosphorous transition state in KBPAP, His and His from one subunit and Arg from other subunit participate(17) . It appears that the stabilizing effect of phosphate on binding to active site of KBPAP was steric. By restricting the movement of the loop containing Arg, opening up of the subunit interface could be prevented. In the phosphate-stabilized protein, the restriction on movement of various segments restricts the number of intermediates that could form, and consequently it unfolds with a single intermediate. Similar ligand stabilizations were observed with the catalytic trimer of Escherichia coli aspartate transcarbamylase in the presence of carbamyl phosphate (2) and in E. coli dehydroquinase with covalently bound substrate(10, 28) . In the case of 20-beta-hydroxysteroid dehydrogenase, NADH was shown to alter the unfolding pathway(30) . The effects reported in this paper were observed at a phosphate concentration in the range of its inhibition constant (i.e. 1.8 mM). The dissociation constant of phosphate calculated based on the denaturation curves was similar to the K(d) value obtained based on activity inhibition. Further, these effects were duplicated with other active site binding ligands, indicating that phosphate-induced stabilization was strictly ligand-induced effects and not specific to phosphate. Also, the protective effect of phosphate toward KBPAP denaturation was observed even during thermal denaturation. Stability of a protein was known to be intimately related to its in vivo life times, since unfolded proteins are considered to be substrates for cytosolic proteases(3) . Near doubling in stabilization energies indicate phosphate may have a physiological role of stabilizing KBPAP in vivo.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 91-40-672241; Fax: 91-40-671195; :madhu{at}ccmb.uunet.in.

(^1)
The abbreviations used are: KBPAP, red kidney bean purple acid phosphatase; ATPS, adenosine 5`-O-(thiotriphosphate); ANS, 8-anilinonaphthalene 1-sulfonic acid; GdmCl, guanidinium chloride; FPLC, fast protein liquid chromatography; SEC, size exclusion chromatography.

(^2)
A. G. Cashikar and N. M. Rao, submitted for publication.


REFERENCES

  1. Jencks, W. P. (1975) Adv. Enzymol. 43, 219-410 [Medline] [Order article via Infotrieve]
  2. Bromberg, S., Licata, V. J., Mallikaracchi, D., and Allewell, N. M. (1994) Protein Sci. 3, 1236-1244 [Abstract/Free Full Text]
  3. Pace, C. N. (1990) Trends Biochem. Sci. 15, 14-17 [CrossRef][Medline] [Order article via Infotrieve]
  4. Pace, C. N., and McGrath, T. (1980) J. Biol. Chem. 255, 3862-3865 [Abstract/Free Full Text]
  5. Grisolia, S. (1964) Physiol. Rev. 44, 657-712 [Free Full Text]
  6. Schmid, R. D. (1979) Adv. Biochem. Eng. 12, 41-118
  7. Citri, N. (1973) Adv. Enzymol. 37, 397-648 [Medline] [Order article via Infotrieve]
  8. Noble, M. E. M., Wierenga, R. K., Lambeir, A-M., Opperdoes, F. R., Thunnissen, A. W. H., Kalk, K. H., Groendijk. K. H., and Hol, W. G. J. (1991) Proteins: Structure, Function and Genetics 10, 50-69
  9. Cheetham, J. C., Artymuik, P. J., and Phillips, D. C. (1992) J. Mol. Biol. 224, 613-628 [Medline] [Order article via Infotrieve]
  10. Reilly, A., Morgan, P., Davis, K., Kelly, S. M., Greene, J., Rowe, A. J., Harding, S. E., Price, N. C., Coggins, J. R., and Kleanthous, C. (1994) J. Biol. Chem. 269, 5523-5526 [Abstract/Free Full Text]
  11. Pace, C. N., and Grimsley, G. R. (1988) Biochemistry 27, 3242-3246 [Medline] [Order article via Infotrieve]
  12. Beck, J. L., McConachie, L. A., Summors, A. C., Arnold, W. N., DeJersey, J., and Zerner, B. (1986) Biochim. Biophys. Acta 869, 61-68
  13. Cashikar, A. G., and Rao, N. M. (1995) Indian J. Biochem. Biophys. 32, 130-136 [Medline] [Order article via Infotrieve]
  14. Klabunde, T., Stahl, B., Suerbaum, H., Hahner, S., Karas, M., Hillenkamp, F., Krebs, B., and Witzel, H. (1994) Eur. J. Biochem. 226, 369-375 [Abstract]
  15. Suerbaum, H., Korner, M., Witzel, H., Althaus, E., Mosel, B-D., and Muller-Warmuth, W. (1993) Eur. J. Biochem. 214, 313-321 [Abstract]
  16. Klabunde, T., Strater, N., Krebs, B., and Witzel, H. (1995) FEBS Lett. 367, 56-60 [CrossRef][Medline] [Order article via Infotrieve]
  17. Strater, N., Klabunde, T., Tucker, P., Witzel, H., and Krebs, B. (1995) Science 268, 1489-1492 [Medline] [Order article via Infotrieve]
  18. Duff, S. M. G., Sarath, G., and Plaxton, W. C. (1994) Physiol. Plant. 90, 791-800 [CrossRef]
  19. Gibson, D. M., and Ullah, A. H. (1988) Arch. Biochem. Biophys. 260, 503-513 [Medline] [Order article via Infotrieve]
  20. Cornish-Bowden, A. (1976) Principles of Enzyme Kinetics , pp. 23-28, Butterworths, London
  21. Lakowicz, J. R. (1983) Principles of Fluorescence Spectroscopy , pp. 257-295, Plenum Press, New York
  22. Uversky, V. N. (1993) Biochemistry 32, 13288-13298 [Medline] [Order article via Infotrieve]
  23. Schellman, J. A. (1975) Biopolymers 14, 999-1018
  24. Schmid, F. X. (1992) in Protein Folding (Creighton, T. E., ed) pp. 197-241, W. H. Freeman and Co., New York
  25. Pace, C. N. (1986) Methods Enzymol. 131, 266-280 [Medline] [Order article via Infotrieve]
  26. Stryer, L. (1965) J. Mol. Biol. 13, 482-495 [Medline] [Order article via Infotrieve]
  27. Pace, C. N., Shirley, B. A., and Thomson, J. A. (1988) in Protein Structure: A Practical Approach (Creighton, T. E., ed) pp. 311-330, IRL Press, Oxford
  28. Kleanthous, C., Reilly, M., Cooper, A., Kelly, S., Price, N. C., and Coggins, J. R. (1991) J. Biol. Chem. 266, 10893-10898 [Abstract/Free Full Text]
  29. Creighton, T. E. (1992) Protein Folding W. H. Freeman Press, New York
  30. Vecchio, G., Pasta, P., Mazzola, G., and Carrea, G. (1987) Biochim. Biophys. Acta 914, 122-126 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.